{{Rsnum
|rsid=10508198
|Gene=TNFSF13B
|Chromosome=13
|position=108290440
|Orientation=plus
|GMAF=0.1979
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=LOC102724347,TNFSF13B
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 12.3 | 36.9 | 50.8
| HCB | 0.0 | 15.6 | 84.4
| JPT | 0.0 | 38.6 | 61.4
| YRI | 1.6 | 12.7 | 85.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 15.6 | 84.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19604268
|Title=Association between total immunoglobulin E and antibody responses to naturally acquired Ascaris lumbricoides infection and polymorphisms of immune system-related LIG4, TNFSF13B and IRS2 genes
|OA=1
}}

{{PMID Auto
|PMID=19383901
|Title=Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}